To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3191 | Ly-465608 |
Novel potent and selective dual PPARalpha/gamma agonist
More description
|
|
| DCC3190 | Ly456236 Hydrochloride |
Selective mGlu1 receptor antagonist
More description
|
|
| DCC3189 | Ly451646 |
AMPA receptor potentiator
More description
|
|
| DCC3188 | Ly444711 |
Orally active ghrelin agonist, bindjng with high affinity to and being a potent activator of the growth hormone secretagogue receptor 1a (GHS-R1a) receptor
More description
|
|
| DCC3187 | Ly-395153 |
Allosteric modulator of AMPA receptors
More description
|
|
| DCC3186 | Ly392098 |
AMPA receptor potentiator
More description
|
|
| DCC3185 | Ly382884 |
Selective GluR5 kainate receptor antagonist
More description
|
|
| DCC3184 | Ly339434 |
Potent GluR5 kainate receptor agonist
More description
|
|
| DCC3183 | Ly-333531 Mesylate |
Potent and selective inhibitor of PKCβI and PKCβII
More description
|
|
| DCC3182 | Ly2979165 Ammonium Salt |
Novel highly potent and selective agonist of metabotropic glutamate (mGlu) receptors 2 and 3
More description
|
|
| DCC3180 | Ly2934747 |
Novel, potent, and systemically bioavailable mGlu2/3 receptor agonist, exhibiting both antipsychotic and analgesic properties in vivo
More description
|
|
| DCC3179 | ly2886721 Hydrochloride |
Orally active cell-permeable inhibitor of human
More description
|
|
| DCC3178 | Ly-278584 |
Potent 5-HT3 serotonin receptor antagonist
More description
|
|
| DCC3177 | Ly2389575 |
Selective negative allosteric modulator of mGlu3
More description
|
|
| DCC3176 | Ly-231617 |
Potent antioxidant, being cytoprotective in models of focal and global cerebral ischemia
More description
|
|
| DCC3175 | ly-2140023 |
Novel mGlu2/3 receptor agonist; Prodrug of LY-404039
More description
|
|
| DCC3174 | ly-2121260 |
Novel glucokinase activator (GKA)
More description
|
|
| DCC3173 | Ly2048978 |
Novel, potent, orally-bioavailable kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders
More description
|
|
| DCC3172 | Ly2019-006 |
Novel LRRK2 kinase inhibitor against the wild-type and G2019S mutant LRRK2 kinase being 1526.00 ± 0.87 nM, 1165.00 ± 1.18 nM, respectively
More description
|
|
| DCC3171 | Ly2019-005 |
Novel LRRK2 kinase inhibitor against the wild-type and G2019S mutant LRRK2 kinase being 424.40 ± 1.31 nM, 378.80 ± 1.20 nM, respectively
More description
|
|
| DCC3170 | Lxy6090 |
Novel potent HIF-1 inhibitor, also downregulating the protein level of HIF-1alpha, which depended on von Hippel-Lindau for proteasome degradation, showing in vivo anticancer efficacy by decreasing the HIF-1alpha expression in nude mice bearing MX-1 tumor
More description
|
|
| DCC3169 | Lxy6006 |
Novel Manassantin A Derivative, Inhibiting Hypoxia-Inducible Factor 1 and Tumor Growth
More description
|
|
| DCC3168 | lxrβ-agonist-19 |
Novel selective LXRβ agonist, reducing total brain Aβ
More description
|
|
| DCC3167 | Lx7101 Hydrochloride |
Novel Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma
More description
|
|
| DCC3166 | Luminolate (luminol Sodium Salt) |
Immune modulator with SARS-CoV-2 antiviral activity via a multi-target mechanism including localized, self-limiting reactive oxygen species (ROS) scavenging activities that were demonstrated in a model of lipopolysaccharide (LPS)-induced joint inflammatio
More description
|
|
| DCC3165 | Luminespib Mesylate |
Novel inhibitor of heat shock protein 90 (Hsp90)
More description
|
|
| DCC3164 | Lugdunin |
Thiazolidine-containing cyclic peptide antibiotic, suppressing growth of species of disease-causing bacteria in that part of the human microbiome
More description
|
|
| DCC3163 | Luf-6258 |
Hybrid ortho/allosteric ligand of the adenosine A(1) receptor
More description
|
|
| DCC3162 | Luf-6056 |
Human adenosine A1 receptor antagonist
More description
|
|
| DCC3161 | Luf-5764 |
A1 adenosine receptor antagonist
More description
|
|